September 25, 2015
CHMP reccomends Bayer’s Eye medicine for approval in EU
The European Committee for Medicinal Products for Human Use (CHMP) has recommended Bayer’s aflibercept solution for injection into the eye…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
September 25, 2015
Novartis: New NIBR director named. Entresto closer to be available EU
Switzerland-based Novartis has today appointed Dr. James E. Bradner, physician-scientist from Dana-Farber Cancer Institute and Harvard Medical School, as President of the…
September 25, 2015
‘Novartis Access’, a portfolio of affordable medicines to treat chronic diseases in lower-income countries
Novartis has announced the launch of Novartis Access, a portfolio of 15 medicines to treat chronic diseases in low- and…
September 23, 2015
Phase 3 study of ABP 215 meets its endpoints
Amgen and Allergan plc. announced on Wednesday that a Phase 3 study of biosimilar candidate ABP 215 met its primary…
September 22, 2015
Biofrontera: Ameluz and BF-RhodoLED a great team in photodynamic field therapy
Biofrontera, the biopharmaceutical company focusing on sun-induced skin cancer, has announced that preliminary long-term results of the Phase III trial for…
September 21, 2015
Allergan challenges Generic Rytary Patent in USA
Allergan, a Dublin-headquartered pharmaceutical company, confirmed on Monday that it has filed an Abbreviated New Drug Application (ANDA) with the…
September 21, 2015
Allergan partners with Caregiver Action Network to provide 1000 thank you meals
Allergan has announced a nationwide partnership with the Caregiver Action Network (CAN), a family caregiver organization, to provide thank you meals to 1,000…
September 18, 2015
Bayer in structural reorganization. Jobs to remain stable
The Supervisory Board of Bayer has approved the reorganization proposed by the Board of Management, so that from January 1,…
You must be logged in to post a comment.